Natus welcomes Optima Medical to the Natus family of solutions
The shareholders of Optima Medical Limited have sold the company to Natus Medical Incorporated.
Optima Medical is one of the UK and Ireland’s leading supplier of neurodiagnostic equipment and accessories (EEG, Sleep, EMG, IOM). Since it was founded in 1999, Optima has installed thousands of systems in hospitals throughout the UK and Ireland. The company has built its reputation through supplying high-performance equipment combined with technical and clinical expertise. Its team consists of highly experienced engineers, product experts and clinical specialists trained and qualified to support customers throughout the life of their equipment.
Natus delivers solutions to screen, diagnose and treat disorders affecting the brain, neural pathways and eight sensory nervous systems, its aim being to advance the standard of care and improve patient outcomes and quality of life. Natus offers hardware, advanced software and algorithms, and consumables that provide stimulus, acquire and monitor physiological signals, and capture the body’s response. With sales in over 100 countries, Natus is a global leader in neurodiagnostics.
With a long-standing history as a trusted distribution partner of Natus Medical, the acquisition of Optima signifies a significant step forward, elevating their already successful partnership to a new phase. Together, they are able to enhance their shared goal of providing industry leading products and exceptional customer support, bringing it closer to their customers within the British Isles.
Oaklins Evelyn Partners, based in the UK, acted as lead advisor to the shareholders of Optima.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Conozca másXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Conozca másMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Conozca más